AI CAPITAL INTELLIGENCE
睿心医疗 · Series D · Approximately CNY 100,000,000 · 2026-05-27
Financing facts, at a glance
睿心医疗: financing disclosed on 2026-05-27, Series D, Approximately CNY 100,000,000. Named investors: 广州生物医药与健康产业投资有限公司, 广州越富基金管理有限公司, 广州健康产投, 越富基金. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
Original source 1 · Original source 2 · Original source 3 · Original source 4 · Original source 5 · Original source 6
睿心医疗 is recorded in the Industry AI / Healthcare & clinical AI segment. The disclosed financing is Series D, with an amount of Approximately CNY 100,000,000. Named investors include 广州生物医药与健康产业投资有限公司, 广州越富基金管理有限公司, 广州健康产投, 越富基金.
- Disclosed company name
- 深圳睿心智能医疗科技有限公司
- Disclosure date
- 2026-05-27
- Round
- Series D
- Financing amount
- Approximately CNY 100,000,000
- Market coverage
- China
- Sector
- Industry AI / Healthcare & clinical AI
- Product form
- Enterprise software
Disclosed investors
广州生物医药与健康产业投资有限公司, 广州越富基金管理有限公司, 广州健康产投, 越富基金
Original sources
- Source 1 · news.pedaily.cn
- Source 2 · www.matrixpartners.com.cn
- Source 3 · pitchhub.36kr.com
- Source 4 · 36kr.com
- Source 5 · www.36kr.com
- Source 6 · www.sohu.com
Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.